MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-17-0041794
Pirouzi Private Limited
Pirouzi Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹175.44 Cr
▲ 38% YoY
Net profit · FY 2025
₹37.57 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹54.76 Lakh
EBITDA margin 0.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Pirouzi Private Limited
Data last updated:
Pirouzi Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2021PTC363311. Its GSTIN is 27AAMCP1102B1Z0 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhijeet Suhas Pawar and Devang Kiritkumar Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹175.44 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹37.57 Lakh (net margin 0.2%) and EBITDA of ₹54.76 Lakh (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 141% over three years.
Pirouzi Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0041794).
Company details
CIN U46497MH2021PTC363311
Registration Number 363311
Incorporation Date 05 July 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0041794
CIN history
Pirouzi has one previous CIN (Corporate Identification Number): U24304MH2021PTC363311. The current CIN is U46497MH2021PTC363311, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497MH2021PTC363311 | Current |
| U24304MH2021PTC363311 | Previous |
Recognitions & Rankings of Pirouzi
Contact details
Pirouzi Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address703 7th Floor Sunshine Tower, S. B. Road Dadar West, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Pirouzi Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pirouzi is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pirouzi Private Limited, buy the company report.
Financials of Pirouzi Private Limited
FY 2025 filings availablePirouzi Private Limited reported revenue of ₹175.44 Cr (up 38% YoY) for FY 2025.
Revenue · FY 2025
₹175.44 Cr ▲ 38%
Net profit · FY 2025
₹37.57 Lakh margin 0.2%
EBITDA · FY 2025
₹54.76 Lakh margin 0.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 141%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 141% over three years, including 38% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹54.76 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹37.57 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.3% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Pirouzi Private Limited, buy the company report.
Board of directors of Pirouzi Private Limited
Pirouzi has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhijeet Suhas Pawar | Director | 11 Sep 2024 | 2 Years 1 Months | Current |
| Devang Kiritkumar Shah | Director | 11 Sep 2024 | 2 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Pirouzi Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pirouzi Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pirouzi has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCP1102B1Z0 | Maharashtra | Active | 10 Nov 2021 |
To see the full GST registrations and return filing status of Pirouzi Private Limited, buy the company report.
Recent activity
Pirouzi Private Limited has 7 board changes on record since 2024: 2 appointments and 5 cessations. The latest: Abhijeet Suhas Pawar ceased to be Additional Director on 29 Sep 2024.
AGM
Pirouzi Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pirouzi Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Abhijeet Suhas Pawar ceased to be Additional Director.
Ceased
Devang Kiritkumar Shah ceased to be Additional Director.
Ceased
Dilip Dinesh Ketiwalla ceased to be Director.
Ceased
Ritika Rajesh Jhunjhunwala ceased to be Director.
Appointed
Abhijeet Suhas Pawar was appointed as Director.
Appointed
Devang Kiritkumar Shah was appointed as Director.
Ceased
Abhijit Nirmal Sampat ceased to be Director.
Incorporation
05 Jul 2021
Pirouzi Private Limited was registered on 05 Jul 2021 with Roc Mumbai I & aged 5 years 3 months as per MCA records.
Frequently asked questions
Pirouzi is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2021 (5+ years old) and is registered under CIN U46497MH2021PTC363311.
Pirouzi has 2 current directors:
- Abhijeet Suhas Pawar - Director
- Devang Kiritkumar Shah - Director
The latest financial statements of Pirouzi on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Pirouzi is 27AAMCP1102B1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pirouzi is U46497MH2021PTC363311. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pirouzi was incorporated on 05 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Abhijeet Suhas Pawar ceased to be Additional Director on 29 Sep 2024. Devang Kiritkumar Shah ceased to be Additional Director on 29 Sep 2024. Dilip Dinesh Ketiwalla ceased to be Director on 12 Sep 2024. Pirouzi has 7 board changes on record in total.
Yes, Pirouzi is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0041794).
The registered office of Pirouzi is at 703 7th Floor Sunshine Tower, S. B. Road Dadar West, Mumbai, Maharashtra, India – 400013.
Pirouzi operates in the pharma industry, in the drug formulation and development segment.